By Laurie McGinely
“Amit Narang, regulatory policy advocate at Public Citizen, took issue with the comment. ‘It is completely inaccurate for FDA to claim it is still working on the nicotine levels rulemaking,’ he said. ‘It is listed as withdrawn and as a completed action.”
Read the full story here.